Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Scientists compared high-intensity statins rosuvastatin and atorvastatin, and found both are broadly safe and effective at ...

The seven-year MS-STAT study, which involved almost 1,000 patients over 31 sites across the UK, concluded that simvastatin is ...

Navigating the complex world of prescription drug pricing can feel overwhelming, particularly with the ever-increasing costs ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

A common drug taken by millions of people in the UK has been linked to an increased risk of diabetes. Statins are taken for a ...

A group at NUS Yong Loo Lin School of Medicine (NUS Medicine) has created a nanoparticle technology that provides an efficient and non-invasive way to identify and treat atherosclerosis, according to ...

Compared to the systemic delivery of similar doses of Simvastatin, the nanoparticles can deliver 1000 times more of the drug to the plaques, thereby enhancing the therapeutic efficacy while minimising ...

NUS Medicine researchers unveil breakthrough nanoparticle technology for atherosclerosis diagnosis and treatment Singapore ...

In this article, we discuss the global issue of drug shortages. We summarise our research where we developed a framework for ...